PE20080136A1 - Arilsulfonamidas sustituidas como agentes antivirales - Google Patents
Arilsulfonamidas sustituidas como agentes antiviralesInfo
- Publication number
- PE20080136A1 PE20080136A1 PE2007000224A PE2007000224A PE20080136A1 PE 20080136 A1 PE20080136 A1 PE 20080136A1 PE 2007000224 A PE2007000224 A PE 2007000224A PE 2007000224 A PE2007000224 A PE 2007000224A PE 20080136 A1 PE20080136 A1 PE 20080136A1
- Authority
- PE
- Peru
- Prior art keywords
- phenyl
- arylsulfonamides
- halogen
- amino
- independently
- Prior art date
Links
- 239000003443 antiviral agent Substances 0.000 title 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 4
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 150000002367 halogens Chemical class 0.000 abstract 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 2
- 229910052799 carbon Inorganic materials 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- -1 AMINO Chemical class 0.000 abstract 1
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 abstract 1
- 241000701022 Cytomegalovirus Species 0.000 abstract 1
- 241000700586 Herpesviridae Species 0.000 abstract 1
- 241000701024 Human betaherpesvirus 5 Species 0.000 abstract 1
- FIULGFJIHJJXMT-UHFFFAOYSA-N [C]1[N]C=CC=C1 Chemical compound [C]1[N]C=CC=C1 FIULGFJIHJJXMT-UHFFFAOYSA-N 0.000 abstract 1
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
SE REFIERE A COMPUESTOS ARILSULFONAMIDAS DE FORMULA (I), EN DONDE A ES UN GRUPO a), b), ENTRE OTROS; DONDE * ES EL SITIO DE UNION CON EL CARBONO DEL PIRIDINILO; # ES EL SITIO DE UNION CON EL CARBONO DEL FENILO; R1 ES H, AMINO O METILCARBONILAMINO; R2, R5 Y R6 SON INDEPENDIENTEMENTE H O HALOGENO; R3 YR4 SON INDEPENDIENTEMENTE H, HALOGENO O CIANO; R7 Y R8 SON INDEPENDIENTEMENTE H, HALOGENO O ALQUILO(C1-C3). SON SELECCIONADOS: N-{3-[({4-[5-(6-AMINOPIRIDIN-2-IL)-1,2,4-OXADIAZOL-3-IL]FENIL}SULFONIL)AMINO]-5-FLUOROFENIL}-1-CIANOCICLOPROPANO CARBOXAMIDA, N-{3-[({4-[5-(6-AMINOPIRIDIN-2-IL)-1,2,4-OXADIAZOL-3-IL]FENIL}SULFONIL)AMINO]FENIL}-1-CIANOCICLOPROPANO CARBOXAMIDA, ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA Y UN PROCEDIMIENTO DE PREPARACION. ESTOS COMPUESTOS MUESTRAN ACTIVIDAD ANTIVIRAL SOBRE GRUPOS HERPES VIRIDAE, CITOMEGALOVIRUS Y EN ESPECIAL EL CITOMEGALOVIRUS HUMANO
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102006009928A DE102006009928A1 (de) | 2006-03-03 | 2006-03-03 | Substituierte Arylsulfonamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20080136A1 true PE20080136A1 (es) | 2008-04-18 |
Family
ID=38180640
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2007000224A PE20080136A1 (es) | 2006-03-03 | 2007-03-02 | Arilsulfonamidas sustituidas como agentes antivirales |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US8318761B2 (es) |
| EP (1) | EP1991529B1 (es) |
| JP (1) | JP5255455B2 (es) |
| KR (1) | KR101447758B1 (es) |
| CN (1) | CN101389607B (es) |
| AR (1) | AR059710A1 (es) |
| AT (1) | ATE451356T1 (es) |
| AU (1) | AU2007222689B2 (es) |
| BR (1) | BRPI0707068A2 (es) |
| CA (1) | CA2642602C (es) |
| DE (2) | DE102006009928A1 (es) |
| DK (1) | DK1991529T3 (es) |
| ES (1) | ES2335316T3 (es) |
| IL (1) | IL193449A (es) |
| JO (1) | JO2581B1 (es) |
| MX (1) | MX2008011264A (es) |
| PE (1) | PE20080136A1 (es) |
| PL (1) | PL1991529T3 (es) |
| PT (1) | PT1991529E (es) |
| RU (1) | RU2423352C2 (es) |
| TW (1) | TWI388559B (es) |
| UA (1) | UA95103C2 (es) |
| UY (1) | UY30178A1 (es) |
| WO (1) | WO2007101573A1 (es) |
| ZA (1) | ZA200807189B (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10319612A1 (de) | 2003-05-02 | 2004-11-18 | Bayer Healthcare Ag | Substituierte Dihydrochinazoline |
| EP2103317A1 (de) * | 2008-03-20 | 2009-09-23 | Bayer MaterialScience AG | Medizinische Geräte mit hydrophilen Beschichtungen |
| EP2103316A1 (de) * | 2008-03-20 | 2009-09-23 | Bayer MaterialScience AG | Hydrophile Polyurethandispersionen |
| EP2103318A1 (de) * | 2008-03-20 | 2009-09-23 | Bayer MaterialScience AG | Medizinische Geräte mit hydrophilen Beschichtungen |
| EP2103638A1 (de) * | 2008-03-20 | 2009-09-23 | Bayer MaterialScience AG | Hydrophile Polyurethanlösungen |
| DE102008025613A1 (de) * | 2008-05-28 | 2009-12-03 | Bayer Materialscience Ag | Hydrophile Polyurethanbeschichtungen |
| DE102008025614A1 (de) * | 2008-05-28 | 2009-12-03 | Bayer Materialscience Ag | Hydrophile Polyurethanbeschichtungen |
| AU2009289831A1 (en) | 2008-09-04 | 2010-03-11 | Bayer Materialscience Ag | TCD based hydrophilic polyurethane dispersions |
| DE102011101446A1 (de) * | 2011-05-10 | 2012-11-15 | Aicuris Gmbh & Co. Kg | Herstellung von "Dense Bodies" (DB) |
| EP2853532B1 (en) * | 2013-09-28 | 2020-12-09 | Instytut Farmakologii Polskiej Akademii Nauk | 1,2,4-oxadiazole derivatives as allosteric modulators of metabotropic glutamate receptors belonging to group III |
| CN109879817B (zh) * | 2019-03-19 | 2020-10-02 | 扬州大学 | 甲基二磺隆的制备方法 |
| RU2738848C1 (ru) * | 2019-10-24 | 2020-12-17 | Общество с ограниченной ответственностью "Научно-исследовательский институт ХимРар" (ООО "НИИ ХимРар") | Ингибитор вируса гепатита В (ВГВ), представляющий собой производные N-{ 3-[6-(диалкиламино)пиридазин-3-ил]фенил} арилсульфонамида и производные N-{ 4-[6-(диалкиламино)пиридазин-3-ил]фенил} арилсульфонамида |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19802437A1 (de) | 1998-01-23 | 1999-07-29 | Bayer Ag | Verwendung von substituierten Sulfonamiden als anitvirale Mittel und neue Stoffe |
| US6495578B1 (en) | 1999-04-19 | 2002-12-17 | Shionogi & Co., Ltd. | Sulfonamide derivatives having oxadiazole rings |
| DE19920790A1 (de) * | 1999-05-06 | 2000-11-09 | Bayer Ag | Bis-Sulfonamide mit anti-HCMV-Wirkung |
| DE19930075A1 (de) | 1999-06-30 | 2001-01-04 | Bayer Ag | Neue Amino- und Amidosulfonamide als antivirale Mittel |
| SK12662003A3 (sk) * | 2001-04-19 | 2004-04-06 | Bayer Aktiengesellschaft | Arylsulfónamidy ako antivírusové činidlá |
| DE10138578A1 (de) * | 2001-08-06 | 2003-02-27 | Bayer Ag | Heterocyclylarylsulfonamide |
-
2006
- 2006-03-03 DE DE102006009928A patent/DE102006009928A1/de not_active Withdrawn
-
2007
- 2007-02-26 WO PCT/EP2007/001620 patent/WO2007101573A1/de not_active Ceased
- 2007-02-26 AT AT07722932T patent/ATE451356T1/de active
- 2007-02-26 UA UAA200811582A patent/UA95103C2/ru unknown
- 2007-02-26 AU AU2007222689A patent/AU2007222689B2/en not_active Ceased
- 2007-02-26 BR BRPI0707068-3A patent/BRPI0707068A2/pt not_active Application Discontinuation
- 2007-02-26 RU RU2008139195/04A patent/RU2423352C2/ru active
- 2007-02-26 CA CA2642602A patent/CA2642602C/en active Active
- 2007-02-26 DK DK07722932.6T patent/DK1991529T3/da active
- 2007-02-26 CN CN2007800066327A patent/CN101389607B/zh not_active Expired - Fee Related
- 2007-02-26 ES ES07722932T patent/ES2335316T3/es active Active
- 2007-02-26 PL PL07722932T patent/PL1991529T3/pl unknown
- 2007-02-26 KR KR1020087024156A patent/KR101447758B1/ko not_active Expired - Fee Related
- 2007-02-26 MX MX2008011264A patent/MX2008011264A/es active IP Right Grant
- 2007-02-26 PT PT07722932T patent/PT1991529E/pt unknown
- 2007-02-26 DE DE502007002264T patent/DE502007002264D1/de active Active
- 2007-02-26 JP JP2008557628A patent/JP5255455B2/ja not_active Expired - Fee Related
- 2007-02-26 EP EP07722932A patent/EP1991529B1/de active Active
- 2007-02-28 UY UY30178A patent/UY30178A1/es active IP Right Grant
- 2007-03-01 JO JO200762A patent/JO2581B1/en active
- 2007-03-02 TW TW096107166A patent/TWI388559B/zh not_active IP Right Cessation
- 2007-03-02 PE PE2007000224A patent/PE20080136A1/es active IP Right Grant
- 2007-03-02 AR ARP070100858A patent/AR059710A1/es not_active Application Discontinuation
-
2008
- 2008-08-14 IL IL193449A patent/IL193449A/en active IP Right Grant
- 2008-08-20 ZA ZA2008/07189A patent/ZA200807189B/en unknown
- 2008-09-03 US US12/203,793 patent/US8318761B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20080136A1 (es) | Arilsulfonamidas sustituidas como agentes antivirales | |
| PE20090709A1 (es) | Compuestos heterociclico de 5 miembros | |
| PE20050132A1 (es) | Piperazinas heterociclicas sustituidas | |
| PE20060361A1 (es) | Compuestos heterociclicos como inhibidores de la cinesina mitotica | |
| PE20060374A1 (es) | Inhibidores de cinasa heterociclicos fusionados | |
| PE20121050A1 (es) | Compuestos de n-(1-(4-(1h-pirazol-5-il)ftalazin-1-il)piperidin-4-il)-benzamida sustituidos como antagonistas de la trayectoria hedgehog | |
| PE20071322A1 (es) | Derivados de 2-morfolinopirimidina como inhibidores de fosfatidinoinositol(pi) 3-quinasa | |
| PE20010741A1 (es) | Derivados de piperazina como antagonistas de taquicininas | |
| PE20040780A1 (es) | Compuestos heterociclicos como antagonista de cgrp y procedimiento para su preparacion | |
| PE20081504A1 (es) | Compuestos de biciclocarboxiamida sustituidos | |
| PE20061353A1 (es) | Compuestos de sulfonamida-tiazolopiridina como activadores de glucocinasa | |
| AR077935A1 (es) | Derivados de 3-amino-5 fenil-5,6-dihidro-2h-(1,4)oxazina | |
| PE20011047A1 (es) | Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas | |
| PE20011371A1 (es) | Derivados de 3-(3-isopropil-5-metil-4h-1,2,4-triazol-4-il)-exo-8-azabiciclo[3.2.1]octano como antagonistas de los receptores de quimiocina ccr5 | |
| PE20091621A1 (es) | Derivados de amina como moduladores de la actividad de tlr y composiciones que los contienen | |
| PE20020753A1 (es) | Heteroaromaticos fusionados como activadores de la glucoquinasa | |
| PE20030762A1 (es) | Compuestos heterociclicos como antagonistas nk1 | |
| PE20200293A1 (es) | Inhibidores pirazolicos de magl | |
| PE20090617A1 (es) | Compuestos amino-5-[-4-(difluorometoxi)fenil]-5-fenilimidazolona para la inhibicion de -secretasa | |
| PE20080345A1 (es) | Derivados de piperazina como agonistas del receptor de gpr38 | |
| PE20071254A1 (es) | Derivados de sulfonamidas como agentes moduladores de los receptores de orexina y su preparacion | |
| PE20071156A1 (es) | COMPUESTOS DERIVADOS DE 4,5,6,7-TETRAHIDRO-1H-INDAZOL COMO POTENCIADORES DEL RECEPTOR DEL ACIDO a-AMINO-3-HIDROXI-5-METILISOXAZOL-4-PROPIONICO (AMPA) | |
| AR049696A1 (es) | Derivados de indol | |
| PE20040772A1 (es) | Composicion y actividad antiviral de derivados de piperazina azaindoloxoaceticos | |
| PE20181015A1 (es) | 2-amino-3-fluoro-3-(fluorometil)-6-meti-6-fenil-3,4,5,6-tetrahidropiridinas como inhibidores de bace1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |